News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi (France) (SAN.PA) to Seek More Venture-Capital Deals Like Warp Drive Bio



3/25/2013 8:10:57 AM

Sanofi (SAN), France’s biggest drugmaker, is seeking more deals with venture-capital funds like its partnership with biotechnology company Warp Drive Bio, Chief Executive Officer Chris Viehbacher said. Sanofi teamed with venture-capital firms Third Rock Ventures and Greylock Partners last year to finance Warp Drive Bio, which is using genomic technology to develop new treatments. The Paris-based drugmaker has recruited someone to look at venture-capital projects, though Viehbacher declined to identify the person. “The Warp Drive model where we are doing in-kind contributions for equity, where our researchers are directly involved in the project, that’s to me more where we want to go,” Viehbacher said in an interview in Lyon, France.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES